Vote Scores

Home / Companies / Jiangsu Hengrui Pharmaceuticals Co., Ltd. / 16 Sep 2025

Meeting · year to 30 June 202648 filers reporting

Jiangsu Hengrui Pharmaceuticals Co., Ltd.: meeting of 16 Sep 2025

Votes reported on Form N-PX, item by item

48 Form N-PX filers reported votes at the Jiangsu Hengrui Pharmaceuticals Co., Ltd. meeting of 16 Sep 2025. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

61 vote records from 48 filers. 3 of the 48 filers that marked the item either way voted against management.

91.7% for2.1% against6.3% other6.3% against management48 filers71.9% for0.7% against27.4% other27.4% against management48,328,327 reported shares
2

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

12 vote records from 4 filers. 0 of the 4 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management4 filers100.0% for0.0% against0.0% against management2,051,832 reported shares, counted once per item in this group
3

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

168 vote records from 44 filers. 6 of the 44 filers that marked the item either way voted against management.

86.4% for11.4% against2.3% other13.6% against management44 filers64.4% for7.7% against27.9% other35.6% against management141,929,349 reported shares, counted once per item in this group
4

OTHERIssuer

OTHER: management items

Management items in this category are shown together; filers word and number them differently.

5 vote records from 5 filers. 0 of the 1 filers that marked the item either way voted against management. 4 filers reported this item without a management mark.

20.0% for0.0% against80.0% other0.0% against management5 filers100.0% for0.0% against0.0% against management334,600 reported shares, counted once per item in this group

How the largest families voted

Family1. Auditor
VanguardFor
BlackRock and iSharesFor
FidelityFor
InvescoAbstain or withhold *
J.P. MorganFor
Goldman SachsFor
T. Rowe PriceFor
Lincoln FinancialFor
Columbia ThreadneedleFor
BNY MellonFor
Capital Group and American FundsFor
AllianceBernsteinAbstain or withhold *
Lord AbbettFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Jiangsu Hengrui Pharmaceuticals Co., Ltd. meeting?

48 Form N-PX filers reported votes at the meeting of 16 Sep 2025. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Jiangsu Hengrui Pharmaceuticals Co., Ltd. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Jiangsu Hengrui Pharmaceuticals Co., Ltd. with a meeting date within three days of 16 Sep 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.